or Try an Advanced Search...

    Technical Analysis for ALBT - Avalon GloboCare Corp.

    Grade Last Price % Change Price Change
    F 2.69 -3.24% -0.09
    ALBT closed unchanged on Wednesday, November 20, 2024, on 2 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ALBT trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction -3.24%
    Inside Day Range Contraction -3.24%
    Wide Bands Range Expansion -3.24%
    Wide Bands Range Expansion -3.24%
    MACD Bearish Signal Line Cross Bearish -0.74%
    Wide Bands Range Expansion -0.74%
    Gapped Down Weakness -0.74%
    20 DMA Resistance Bearish -14.60%
    Narrow Range Bar Range Contraction -14.60%
    Wide Bands Range Expansion -14.60%
    Older End-of-Day Signals for ALBT ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 5 hours ago
    Outside Day about 5 hours ago
    Down 5% about 5 hours ago
    Down 3% about 5 hours ago
    Up 3% about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ALBT Chart by TradingView
    Basic chart:

    Profile

    Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
    Classification
    Sector: Healthcare
    Industry: Medical Care
    Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles

    Is ALBT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 (ALBT) - Analyzing Avalon Globocare's Short Interest
    Nov 18 Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device
    Nov 15 Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023)
    Nov 4 Top Premarket Decliners
    Oct 31 Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales
    Oct 25 Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
    Oct 25 EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer
    Oct 24 Avalon GloboCare announces 1-for-15 reverse stock split as part of Nasdaq compliance plan
    Oct 24 Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan
    Oct 9 Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device
    See more ALBT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.6
    52 Week Low 2.12
    Average Volume 814,417
    200-Day Moving Average 4.93
    50-Day Moving Average 3.16
    20-Day Moving Average 3.16
    10-Day Moving Average 3.09
    Average True Range 0.54
    RSI (14) 43.18
    ADX 22.85
    +DI 29.41
    -DI 24.15
    Chandelier Exit (Long, 3 ATRs) 3.06
    Chandelier Exit (Short, 3 ATRs) 3.75
    Upper Bollinger Bands 3.96
    Lower Bollinger Band 2.36
    Percent B (%b) 0.26
    BandWidth 50.79
    MACD Line -0.11
    MACD Signal Line -0.08
    MACD Histogram -0.0363
    Fundamentals Value
    Market Cap 30.58 Million
    Num Shares 11 Million
    EPS -0.93
    Price-to-Earnings (P/E) Ratio -2.99
    Price-to-Sales 4.16
    Price-to-Book 7.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.05
    Resistance 3 (R3) 3.05 2.96 3.00
    Resistance 2 (R2) 2.96 2.89 2.96 2.99
    Resistance 1 (R1) 2.87 2.85 2.91 2.87 2.97
    Pivot Point 2.78 2.78 2.80 2.78 2.78
    Support 1 (S1) 2.69 2.71 2.74 2.69 2.59
    Support 2 (S2) 2.60 2.67 2.60 2.57
    Support 3 (S3) 2.51 2.60 2.56
    Support 4 (S4) 2.51